Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma

Hypoxia is a predominant feature in glioblastoma (GBM) and contributes greatly to its drug resistance. However, the molecular mechanisms which are responsible for the development of the resistant phenotype of GBM under hypoxic conditions remain unclear. To analyze the key pathways promoting therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yixing, Liu, Bao, Feng, Lan, Sun, Binda, He, Shu, Yang, Yidong, Wu, Gang, E, Guoji, Liu, Chang, Gao, Yuqi, Zhang, Erlong, Zhu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367651/
https://www.ncbi.nlm.nih.gov/pubmed/30775317
http://dx.doi.org/10.3389/fonc.2019.00033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367651/
https://www.ncbi.nlm.nih.gov/pubmed/30775317
http://dx.doi.org/10.3389/fonc.2019.00033

Ejemplares similares